KINTOR PHARMA-B News

KINTOR PHARMA-B: ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2023

Apr 29 00:15 ET

KINTOR PHARMA-B: VOLUNTARY ANNOUNCEMENT PHASE II CLINICAL TRIAL OF GT20029 FOR TREATMENT OF ANDROGENETIC ALOPECIA IN CHINA REACHED PRIMARY ENDPOINT

Apr 21 06:17 ET

KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 5 04:32 ET

KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 4 03:31 ET

KINTOR PHARMA-B: Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Feb 22 03:32 ET

KINTOR PHARMA-B: Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

Feb 22 03:30 ET

KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 5 03:31 ET

KINTOR PHARMA-B: VOLUNTARY ANNOUNCEMENT - CLINICAL TRIAL OF KX-826 AND MINOXIDIL COMBINATION THERAPY FOR THE TREATMENT OF MALE AGA RECEIVED CLEARANCE BY CHINA NMPA

Feb 1 03:46 ET

KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Jan 2 03:37 ET

KINTOR PHARMA-B: VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE BY CHAIRMAN OF THE BOARD, EXECUTIVE DIRECTOR AND CHIEF EXECUTIVE OFFICER

Dec 20, 2023 03:42 ET

KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023

Dec 1, 2023 03:54 ET

KINTOR PHARMA-B: INSIDE INFORMATION RESULTS OF KX-826 PHASE III CLINICAL TRIAL FOR TREATMENT OF MALE AGA IN CHINA

Nov 26, 2023 18:46 ET

KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023

Nov 6, 2023 03:12 ET

KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023

Oct 4, 2023 02:17 ET

KINTOR PHARMA-B: Notification Letter to Non-registered holders - Notice of Publication of 2023 Interim Report and Request Form

Sep 27, 2023 04:33 ET

KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023

Sep 4, 2023 00:33 ET

KINTOR PHARMA-B: VOLUNTARY ANNOUNCEMENT - COMPLETION OF PATIENT ENROLLMENT IN PHASE II CLINICAL TRIAL OF GT20029 FOR TREATMENT OF ANDROGENETIC ALOPECIA IN CHINA

Aug 22, 2023 04:35 ET

KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023

Aug 1, 2023 04:29 ET

KINTOR PHARMA-B: VOLUNTARY ANNOUNCEMENT - COMPLETION OF FIRST PATIENT ENROLLMENT IN LONG-TERM SAFETY PHASE III TRIAL OF KX-826 FOR TREATMENT OF AGA

Jul 19, 2023 07:59 ET

KINTOR PHARMA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023

Jul 3, 2023 04:54 ET